Search

everythinglearnresearchcommunity

for

Search:↓

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

A mutation in the Sgkl gene causes defective hair growth in mice.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

K31 can identify clear secretory cells in human sweat glands.

Human tissue kallikreins help regulate skin barrier functions and affect skin health.

Ptprq has multiple forms that change during inner ear development.

The frizzy mouse and hairless rat mutations are due to changes in the Prss8 gene.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

The enzyme Rand protease works well for leather dehairing and its stability is important, with Leu75 playing a key role.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

RAPK is a rare skin disorder with pigmented spots, mainly on hands and feet, starting in youth.

Efficient enzyme function relies on specific residue interactions and structural coordination.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

New mutations in KRT83 and KRT86 are linked to the hair disorder monilethrix.